Archived Seminar: Unlocking the Neurodevelopmental Effects of Cannabis and Relevance to Psychiatric Risk
Pioneers in Biomedical Research Seminar presented by the Fralin Biomedical Research Institute at VTC
Archived Seminar: Unlocking the Neurodevelopmental Effects of Cannabis and Relevance to Psychiatric Risk
Date: Oct. 23, 2020
Time: 11:00 a.m. - 12:00 p.m.
Abstract
The sociopolitical landscape has dramatically changed regarding the medical and recreational use of cannabis. This talk will provide insights about advances made about the molecular underpinnings of developmental cannabis/THC exposure that maintains a long-term impact on adult behavior. The research describes translational and multidisciplinary scientific approaches ranging from molecular and epigenetic studies in animal models to investigations in human subjects.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Center for Human Neuroscience Research. The Fralin Biomedical Research Institute Pioneers in Biomedical Research Program offers the expertise of a range of scientists who are exploring frontiers in biomedical research. These seminars are open to Virginia Tech and Carilion Clinic faculty, students, and staff.
You May Also Be Interested In...
-
Home ItemSudden Cardiac Arrest in the Young: The Case of ARVC , home
Oct. 18, 2024, 11:00 a.m. | Mario Delmar, M.D., Ph.D., Endowed Professor of Medicine, Patricia and Robert Martinsen Professor of Cardiology, Leon H Charney Division of Cardiology, New York University School of Medicine | Pioneers in Biomedical Research Seminar, Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research
-
Home ItemHarnessing Interoception: Innovative Approaches for Psychiatric Assessment and Intervention , home
Oct. 25, 2024, 11:00 a.m. | Sahib Khalsa, M.D., Ph.D., Associate Professor, Louis Jolyon West Innovation Chair, Director of Anxiety Disorders Research, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles| Co-Sponsored by the Center for Health Behaviors Research and the Addiction Recovery Research Center, Fralin Biomedical Research Institute
-
Home ItemClinical Applications of Cancer Genetics , home
Nov. 21, 2024, 5:30 p.m. (Reception at 5 p.m.) | Luis Diaz, Jr., M.D., Head, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center; Member, National Academy of Medicine | Maury Strauss Distinguished Public Lecture
-
Home ItemA Ribocentric View of Muscle Proteostasis in Health and Disease: Novel Mechanisms Potential Therapeutic Opportunities , home
Nov. 22, 2024, 11:00 a.m. | Gustavo A. Nader, Ph.D., FAPS, Professor, College of Health and Human Development; Chair, Molecular, Cellular, and Integrative Physiology; Huck Institutes of the Life Sciences; The Pennsylvania State University | Co-Sponsored by the Fralin Biomedical Research Institute Center for Exercise Medicine Research
-
Home ItemHuman Laboratory Evaluation of Cannabis Products , home
Dec. 13, 2024, 11:00 a.m. | Ryan Vandrey, Ph.D., Professor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Health Behaviors Research and the Addiction Recovery Research Center
Yasmin Hurd, Ph.D.
Professor in the Department of Psychiatry, Neuroscience, and Pharmacology, and the Department of Systems Therapeutics, at the Icahn School of Medicine; and Director of the Addiction Institute at Mount Sinai